🇬🇧 Overseas Registration Exam (ORE) · subject

Overseas Registration Exam (ORE) Human Disease, Pharmacology and Therapeutics Syllabus

The Human Disease, Pharmacology and Therapeutics syllabus for Overseas Registration Exam (ORE) in full: 4 chapters, 15 topics and 15 sub-topics, every one listed below, plus 52 Human Disease, Pharmacology and Therapeutics flashcards with answers.

4Chapters
15Topics
15Sub-topics
52Flashcards

Human Disease, Pharmacology and Therapeutics syllabus: all 4 chapters

Expand any chapter to see its topics and sub-topics.

  1. Medical History and Risk Assessment

    3 topics
    • Structured History Taking and the ASA Classification
    • Identifying the Medically Compromised Patient
    • Liaison with Medical Practitioners and Referral
  2. Systemic Disease and Dental Implications

    5 topics
    • Cardiovascular Disease
      • Hypertension, ischaemic heart disease and arrhythmias
      • Anticoagulants, antiplatelets and bleeding risk
    • Endocrine and Metabolic Disorders
      • Diabetes mellitus and glycaemic control
      • Thyroid, adrenal and steroid-treated patients
    • Respiratory and Renal Disease
      • Asthma and COPD considerations
      • Renal failure, dialysis and drug dosing
    • Haematological Disorders and Bleeding Diatheses
    • Neurological, Hepatic and Immunological Conditions
  3. Pharmacology and Prescribing

    4 topics
    • Principles of Pharmacokinetics and Pharmacodynamics
    • Drugs Used in Dentistry
      • Analgesics and the WHO analgesic ladder
      • Antimicrobials, antifungals and antivirals
      • Sedatives and emergency drugs
    • Safe and Legal Prescribing
      • The Dental Practitioners' Formulary and BNF
      • Controlled drugs legislation and record keeping
    • Drug Interactions and Adverse Reactions
  4. Pain and Anxiety Control

    3 topics
    • Local Anaesthesia
      • Agents, techniques and maximum safe doses
      • Failure, complications and management
    • Conscious Sedation
      • Inhalation sedation with nitrous oxide
      • Intravenous midazolam and patient monitoring
    • General Anaesthesia: Indications and Referral

Overseas Registration Exam (ORE) Human Disease, Pharmacology and Therapeutics flashcards — 52 questions with answers

  1. What does the ASA Physical Status Classification System assess, and how many grades does it have?

    It is a system (American Society of Anesthesiologists) used to assess a patient's pre-operative physical/medical fitness for anaesthesia or treatment. It has 6 grades (ASA I to VI), with an 'E' suffix added for emergency procedures.

  2. Define ASA I to ASA III in the ASA Physical Status Classification.

    ASA I: a normal healthy patient. ASA II: a patient with mild systemic disease (e.g. well-controlled diabetes, mild asthma, smoker). ASA III: a patient with severe systemic disease that is not incapacitating (e.g. poorly controlled diabetes, stable angina).

  3. Define ASA IV, V and VI in the ASA Physical Status Classification.

    ASA IV: severe systemic disease that is a constant threat to life (e.g. unstable angina, recent MI). ASA V: a moribund patient not expected to survive 24 hours without the operation. ASA VI: a declared brain-dead patient whose organs are being removed for donation.

  4. What are the key components of a structured dental/medical history (the mnemonic order)?

    Presenting complaint (PC); history of presenting complaint (HPC); past medical history (PMH); past dental history (PDH); drug/medication history; family history; social history (smoking, alcohol, occupation); and a systems review.

  5. What features in a patient's history should raise suspicion that they are 'medically compromised'?

    Multiple regular medications, recent hospital admission, breathlessness/chest pain on exertion, uncontrolled chronic disease, recent surgery, bleeding tendencies, immunosuppression, and reduced exercise tolerance (e.g. inability to climb a flight of stairs without stopping).

  6. What information should a dental referral letter to a medical practitioner contain?

    Patient identification details, the reason for referral, a clear specific question being asked, relevant dental findings and proposed treatment, the patient's current medications and medical history as known, and the referrer's contact details and urgency.

  7. Why might a dentist liaise with a patient's GP or physician before treatment?

    To confirm or clarify the medical history and current medications, assess control of systemic disease, obtain advice on anticoagulant/antiplatelet management, check fitness for sedation/GA, arrange antibiotic or steroid cover, and confirm safety of prescribing.

  8. What is the recommended management of a patient on warfarin requiring a dental extraction, including the INR threshold?

    Do not routinely interrupt warfarin. Check the INR ideally within 24 hours (up to 72 hours if stable) before surgery; proceed with local measures if INR is below 4.0. Use local haemostatic measures (sutures, oxidised cellulose, tranexamic acid mouthwash).

  9. For a patient with stable angina, what precautions should be taken during dental treatment?

    Ensure the patient brings their GTN spray, keep appointments short and stress-free, provide good local anaesthesia, treat in a semi-reclined position, and have GTN available. Consider treating later in the morning. Avoid elective treatment if angina is unstable.

  10. What is the current guidance on antibiotic prophylaxis for infective endocarditis in dental patients (NICE)?

    NICE does not recommend routine antibiotic prophylaxis solely to prevent infective endocarditis for dental procedures, but it may be considered for people at increased risk after discussion with the cardiologist/patient. Good oral hygiene is emphasised as more important.

  11. How long should elective dental treatment ideally be deferred after a myocardial infarction, and why?

    Elective treatment should be deferred for at least 6 months (some sources say 3-6 months) after an MI, because the risk of re-infarction and arrhythmia is highest in this period.

  12. What is the maximum recommended dose of adrenaline-containing local anaesthetic in a patient with significant cardiovascular disease?

    Limit adrenaline (epinephrine) to about 0.04 mg total (roughly 2 cartridges of 2% lidocaine with 1:80,000 adrenaline). Use careful aspiration and slow injection to avoid intravascular delivery and a sympathetic surge.

  13. What are the signs and emergency management of a hypoglycaemic episode in the dental chair?

    Signs: sweating, shaking, confusion, slurred speech, aggression, then loss of consciousness. Management: if conscious give 15-20 g fast-acting oral glucose; if unconscious give 1 mg IM glucagon or IV glucose, and call for emergency help.

  14. Which is the more immediate dental emergency in a diabetic patient: hypoglycaemia or hyperglycaemia, and why?

    Hypoglycaemia, because it develops rapidly and can cause loss of consciousness, seizures and brain damage within minutes. Hyperglycaemia (and ketoacidosis) develops over hours to days and is less of an acute chairside emergency.

  15. What is an Addisonian (adrenal) crisis and how is it managed in the dental setting?

    An acute deficiency of cortisol, often precipitated by stress in a patient on long-term steroids or with Addison's disease. Signs: hypotension, collapse, pallor. Management: lay flat, give 100 mg IV/IM hydrocortisone, call emergency services, give oxygen.

  16. What precaution may be needed for a patient on long-term corticosteroids undergoing a stressful dental procedure?

    They may have adrenal suppression and be unable to mount a stress response, so steroid cover may be considered for major procedures to prevent an adrenal crisis (though routine doubling for minor dentistry is now often not required—assess stress level).

  17. Why must elective dental treatment for hyperthyroid patients be deferred until they are euthyroid?

    Because stress and adrenaline can precipitate a thyrotoxic crisis (thyroid storm) — a life-threatening state of tachycardia, hyperthermia, arrhythmia and collapse. Adrenaline-containing LA should be used cautiously in uncontrolled hyperthyroidism.

  18. What dental management considerations apply to an asthmatic patient?

    Ensure they bring their inhaler (salbutamol), assess severity/control, avoid known triggers, avoid NSAIDs and aspirin in NSAID-sensitive asthmatics, minimise stress, and be cautious with sedatives that depress respiration.

  19. What is the immediate management of an acute asthma attack in the dental surgery?

    Stop treatment, sit the patient upright, give salbutamol 2 puffs via spacer (repeat as needed), give high-flow oxygen, reassure, and if no improvement or severe, call emergency services and consider repeated salbutamol/nebuliser.

  20. Why should certain drugs be dose-adjusted or avoided in patients with chronic kidney disease?

    Because reduced renal clearance leads to accumulation and toxicity of renally-excreted drugs (e.g. NSAIDs, some antibiotics). NSAIDs can worsen renal function, and drug doses/intervals may need adjustment based on eGFR.

Show the other 32 Human Disease, Pharmacology and Therapeutics flashcards
  1. What dental precautions apply to a patient on renal dialysis (haemodialysis)?

    Treat on the day after dialysis (not the same day) when the patient is least uraemic and heparin has worn off; avoid nephrotoxic drugs; be aware of bleeding tendency, anaemia, hypertension and risk of hepatitis/bloodborne infection.

  2. What is a bleeding diathesis, and name three examples relevant to dentistry.

    A bleeding diathesis is an increased tendency to bleed due to a defect in haemostasis. Examples: haemophilia A (factor VIII deficiency), haemophilia B (factor IX deficiency), von Willebrand disease, and thrombocytopenia.

  3. How does haemophilia A differ from von Willebrand disease in inheritance and deficiency?

    Haemophilia A is X-linked recessive (affecting males) with a deficiency of factor VIII. Von Willebrand disease is usually autosomal dominant (affecting both sexes) with a deficiency or defect of von Willebrand factor, which also impairs platelet adhesion.

  4. What laboratory tests assess the intrinsic, extrinsic and platelet pathways of haemostasis?

    APTT (activated partial thromboplastin time) assesses the intrinsic pathway; PT/INR (prothrombin time) assesses the extrinsic pathway; platelet count and bleeding time/function assess platelet-related haemostasis.

  5. What dental considerations apply to a patient with epilepsy?

    Identify triggers and seizure frequency/control, avoid stress and flashing lights, be aware of gingival hyperplasia from phenytoin, secure airway/instruments, and know the management of a seizure (protect from injury, do not restrain, time the seizure).

  6. When does a tonic-clonic seizure become status epilepticus, and how is it managed in the dental setting?

    When a seizure lasts more than 5 minutes or seizures recur without recovery. Management: protect the patient, give oxygen, give buccal midazolam 10 mg (adult) and call emergency services.

  7. Why are dental patients with liver disease at increased risk of bleeding and drug toxicity?

    The liver produces clotting factors (II, VII, IX, X — vitamin K dependent) so bleeding risk rises; and impaired hepatic metabolism reduces clearance of many drugs (e.g. lidocaine, paracetamol, sedatives), increasing toxicity risk.

  8. What infection-control and prescribing concerns relate to a patient with hepatitis B or C?

    Risk of bloodborne transmission requires strict cross-infection control; impaired liver function affects drug metabolism (reduce/avoid hepatotoxic drugs like paracetamol overdose risk), and bleeding tendency from reduced clotting factors must be assessed.

  9. Define pharmacokinetics and pharmacodynamics.

    Pharmacokinetics is what the body does to the drug — absorption, distribution, metabolism and excretion (ADME). Pharmacodynamics is what the drug does to the body — its mechanism of action and the relationship between concentration and effect.

  10. What are the four processes of pharmacokinetics (ADME)?

    Absorption (drug entering the bloodstream), Distribution (drug spreading to tissues), Metabolism (biotransformation, mainly hepatic), and Excretion (elimination, mainly renal).

  11. Define a drug's elimination half-life ($t_{1/2}$) and its relationship to the elimination rate constant.

    The half-life is the time taken for the plasma concentration of a drug to fall by half. It relates to the elimination rate constant $k$ by $t_{1/2} = \frac{0.693}{k}$, where $0.693 = \ln 2$.

  12. State the formula relating clearance ($CL$), volume of distribution ($V_d$) and elimination half-life.

    $$t_{1/2} = \frac{0.693 \times V_d}{CL}$$ Half-life increases with a larger volume of distribution and decreases with greater clearance.

  13. Define bioavailability and give the formula for absolute bioavailability ($F$).

    Bioavailability is the fraction of an administered dose that reaches the systemic circulation unchanged. Absolute bioavailability is $$F = \frac{AUC_{oral} \times Dose_{IV}}{AUC_{IV} \times Dose_{oral}}$$ Intravenous drugs have $F = 1$ (100%).

  14. What is first-pass metabolism and why is it important?

    First-pass metabolism is the metabolism of an orally-administered drug by the gut wall and liver before it reaches the systemic circulation, reducing bioavailability. It explains why some drugs are far less effective orally than intravenously.

  15. What is the difference between zero-order and first-order kinetics?

    In first-order kinetics a constant fraction of drug is eliminated per unit time (rate proportional to concentration) — most drugs. In zero-order kinetics a constant amount is eliminated per unit time regardless of concentration (saturated enzymes), e.g. alcohol, phenytoin, high-dose aspirin.

  16. Distinguish a drug agonist from an antagonist.

    An agonist binds a receptor and activates it to produce a response (has affinity and efficacy). An antagonist binds the receptor but produces no response, blocking the action of agonists (has affinity but no efficacy).

  17. What is the difference between drug efficacy and potency?

    Efficacy is the maximum effect a drug can produce regardless of dose. Potency is the amount (dose/concentration) of drug required to produce a given effect; a more potent drug achieves the effect at a lower dose (lower $EC_{50}$).

  18. Which analgesics are commonly used in dentistry, and what are first-line choices for dental pain?

    Paracetamol and NSAIDs (ibuprofen) are first-line for dental pain. Ibuprofen is particularly effective for inflammatory dental pain. Opioids (codeine) are less effective for dental pain and reserved for cases where NSAIDs are contraindicated.

  19. What is the first-line antibiotic for dental infection in a non-penicillin-allergic patient, and the alternative if allergic?

    Amoxicillin (or phenoxymethylpenicillin) is first-line. In penicillin allergy, metronidazole or clarithromycin/clindamycin is used. Metronidazole is especially useful for anaerobic infections such as acute periodontal conditions.

  20. What patient advice is essential when prescribing metronidazole, and why?

    Avoid alcohol during treatment and for 48 hours after, because metronidazole inhibits acetaldehyde dehydrogenase, causing a disulfiram-like reaction (flushing, nausea, vomiting, headache, tachycardia).

  21. What legal requirements must appear on a valid prescription in the UK?

    Patient's name, address and age (if under 12); date; the drug name, form, strength, dose and quantity; clear instructions; and the prescriber's signature and address. Controlled drugs need additional handwritten/specified details and total quantity in words and figures.

  22. What additional requirements apply to prescriptions for Schedule 2 and 3 controlled drugs in the UK?

    They must state the drug, form, strength, dose and total quantity in both words and figures, be signed and dated by the prescriber, include the prescriber's address, and (for Schedule 2/3) the prescription is valid for 28 days only.

  23. Define a drug interaction and give an example relevant to dental prescribing.

    A drug interaction is when one drug alters the effect of another. Example: NSAIDs increase the anticoagulant effect of warfarin (raising bleeding risk); fluconazole/miconazole potentiate warfarin; erythromycin/clarithromycin inhibit metabolism of many drugs (CYP3A4).

  24. Why should aspirin and NSAIDs be used cautiously with warfarin and in peptic ulcer patients?

    NSAIDs inhibit platelet function and can cause gastric erosion/bleeding; combined with warfarin they greatly increase bleeding risk by displacing it from protein binding and adding antiplatelet effect. They are contraindicated in active peptic ulcer disease.

  25. Distinguish a Type A from a Type B adverse drug reaction.

    Type A ('Augmented') reactions are dose-dependent, predictable extensions of the drug's pharmacology (e.g. bleeding with warfarin) and are common. Type B ('Bizarre') reactions are unpredictable, not dose-related, often immunological (e.g. penicillin anaphylaxis) and less common.

  26. What is the mechanism of action of local anaesthetics such as lidocaine?

    They reversibly block voltage-gated sodium ($\ce{Na+}$) channels on the nerve membrane, preventing depolarisation and propagation of the action potential, thereby blocking nerve conduction and sensation.

  27. Why is a vasoconstrictor (e.g. adrenaline 1:80,000) added to local anaesthetic solutions?

    It causes local vasoconstriction, which prolongs the duration of anaesthesia, reduces systemic absorption and toxicity, increases depth of anaesthesia, and reduces bleeding at the surgical site.

  28. State the maximum safe dose of 2% lidocaine with 1:80,000 adrenaline and the calculation basis.

    Maximum lidocaine dose is about 4.4 mg/kg (commonly cited up to ~500 mg total with adrenaline). A 2.2 mL cartridge of 2% lidocaine contains 44 mg lidocaine, since $2\% = 20\ \text{mg/mL} \times 2.2\ \text{mL} = 44\ \text{mg}$.

  29. What is the definition of conscious sedation as used in dentistry?

    A technique in which drug(s) produce a state of depression of the central nervous system enabling treatment, but during which verbal contact with the patient is maintained throughout. The drugs/techniques used carry a margin of safety wide enough to render loss of consciousness unlikely.

  30. Compare inhalation sedation (nitrous oxide) and intravenous sedation (midazolam) in dentistry.

    Inhalation (N2O/O2 'relative analgesia'): rapid onset/recovery, easily titratable, mild, good for children and anxious patients, no amnesia, patient can drive home. IV midazolam: deeper sedation, profound amnesia, used in adults, needs cannulation, longer recovery, patient needs an escort and cannot drive for 24 hours.

  31. What is the reversal agent for benzodiazepine (midazolam) over-sedation, and why must patients still be monitored after its use?

    Flumazenil is the benzodiazepine antagonist used to reverse over-sedation. Patients must still be monitored because flumazenil has a shorter half-life than midazolam, so re-sedation can occur as it wears off.

  32. What are the main indications for referral for general anaesthesia in dentistry?

    Failed local anaesthesia or acute infection preventing it, extensive surgery, very young children or patients with severe learning disability/uncooperative behaviour where other methods fail, severe dental anxiety unmanageable by sedation, and medical conditions requiring controlled airway management. GA must be carried out in a hospital with critical-care facilities.

Overseas Registration Exam (ORE) Human Disease, Pharmacology and Therapeutics FAQ

What is in the Overseas Registration Exam (ORE) Human Disease, Pharmacology and Therapeutics syllabus?

Overseas Registration Exam (ORE) Human Disease, Pharmacology and Therapeutics is split into 4 chapters: Medical History and Risk Assessment, Systemic Disease and Dental Implications, Pharmacology and Prescribing and Pain and Anxiety Control. Together they contain 15 topics and 15 sub-topics.

How many chapters are in Overseas Registration Exam (ORE) Human Disease, Pharmacology and Therapeutics?

4 chapters, containing 15 topics and 15 sub-topics. The largest chapter is Systemic Disease and Dental Implications, with 5 topics.

Are there flashcards for Overseas Registration Exam (ORE) Human Disease, Pharmacology and Therapeutics?

Yes — a 52-card Human Disease, Pharmacology and Therapeutics deck, printed in full in the flashcards section of this page and available in the Examius app with spaced repetition. The free plan covers one exam of your choice, including its flashcards; Examius Pro, a one-time purchase, unlocks every other exam and deck.